Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APSTZD in Insomnia Disorder
NCT07420816Phase 2Recruiting
- Sponsor
- Apsen Farmacêutica
- Start
- Aug 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of APSTZD in Insomnia, sponsored by Apsen Farmacêutica. Started Aug 2026; status: recruiting.
02
Drugs
APSTZD
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT07420816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07420816.